Investors.aileronrx.com
Aileron Therapeutics Announces Positive Data from Cohort 1 of …
WEBLow-dose LTI-03 (2.5 mg BID), a Caveolin-1 related peptide, reduced expression of multiple profibrotic proteins in both pathological basal-like cells and …
Actived: 9 days ago
Aileron Therapeutics Announces Initiation of Randomized, Double …
WEBInvestor Contacts: Media Contact: Richard Wanstall, SVP Chief Financial Officer Liz Melone: Aileron Therapeutics 617-256-6622: 617-995-0900: [email protected]
Top Categories
Popular Searched
› Aveanna health care plainville ct
› Central lambton family health team address
› First financial northwest bank health savings
› Healthy hut products australia
› Embark behavioral health eureka
› Android health connect migration
› School health advisory council meeting
› Connecting apps to samsung health
› Key point mental health services
Recently Searched
› Https sandbox dental elwood health
› This is the best healthy homemade substitute for cream of chicken soup
› Anthem mental health account
› Colorado animal health laboratory
› Spires behavioral health center
› Aveanna healthcare stratton ct
› Environmental health and safety officer